Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cambridge Antibody to change name to MedImmune
With this change, AstraZeneca said that it has created one of the world’s leading vertically integrated biotechnology businesses, with more than $1.3 billion in revenues in 2006, a
With this change, AstraZeneca said that it has created one of the world’s leading vertically integrated biotechnology businesses, with more than $1.3 billion in revenues in 2006, a
Paliperidone palmitate is a long-acting injectable ester of the active ingredient in Invega which utilizes Elan’s NanoCrystal Technology. If the new drug application (NDA) is approved, paliperidone palmitate
This new US patent provides for a method of treating a tumor expressing a human papillomavirus (HPV) antigen through the administration of an effective amount of a composition
As part of SVG’s valued-added distribution capabilities, the pharmacies prepare a sales package consisting of a marketing plan, product displays, literature and training seminars for the pharmacists and
Under the terms of the agreement, Warner Chilcott will supply Tilia Fe (norethindrone acetate and ethinyl estradiol tablets, and ferrous fumarate tablets) to Watson Pharma, which will market,
S-nitrosothiols are endogenous molecules that store and transduce nitric oxide, and are critical modulators of airway and vascular smooth muscle tone. Charles Scoggin, chairman of N30 Pharma, said:
Dalton Medicinal Chemistry Partners is utilizing its medicinal chemistry expertise to design and synthesize novel compounds against an antiviral target selected by Boehringer Ingelheim (Canada). Peter Pekos, president
Despite early signals of efficacy, the Phase II studies Cytokine PharmaSciences (CPSI) conducted in Crohn’s disease were dose-limited by local reactions (i.e., phlebitis) to the semapimod-HCl formulation. These
Beckman Coulter Agencourt subsidiary’s Genomic Services performed the sequencing for this study, which was co-authored by James Hartigan, an Agencourt project manager. With these new agreements, Beckman Coulter
Under the terms of the agreement, Endotis has acquired exclusive rights to develop and commercialize Org 42675, Org 217609 (a neutralizable follow-up of Org 42675) and Org 224283,